The ‘Benadryl Challenge’ started in 2020, and like most social media trends, over time, it fizzled out into cyberspace. The challenge calls for participants to record themselves taking fatal doses of Benadryl – around 300mg, which is 12 times the recommended adult dosage – in pursuit of hallucinations, or a euphoric “high”. Ironically, the same…
For the first time in almost 16 years, a first-in-class agent has been introduced to manage hypertension (HTN). The FDA has approved AstraZeneca’s Baxfendy (baxdrostat), an Aldosterone Synthase Inhibitor, in combination with other medications to treat adults with inadequately controlled HTN.[1] Prior to this announcement, the mainstay classes utilized for high blood pressure were Calcium…
The present economic downturn, coupled with 20 states and counting, pulling back their government funding for HIV/AIDs assistance programs could not have been untimelier. Economic pressures and potential budgeting shortfalls are forcing states to revise their spending. As a direct result, life-saving medications and preventative care for many living with HIV/AIDs has become more costly…
What’s new in the GLP-1 market? You guessed it: the second oral GLP-1 therapy is here. On April 1, 2026, Fundayo (orforglipron) received FDA approval for weight reduction and maintenance in adults with obesity or overweight adults with one comorbid condition related to their weight. Importantly, the medication is to be used in combination with…
Utah is the first state to automize prescription refills through an artificial intelligence (AI)-driven platform: Doctronic. No active doctor reviewing in real time. No healthcare provider oversight. Just AI. The AI-driven platform originally went live in late 2023, but it was not until December 2025, that the state of Utah partnered with the platform to provide…
On December 22, 2025, Novo Nordisk shocked the world with breaking news: Wegovy (semaglutide) was FDA-approved in an oral formulation at a dosage of 25mg for weight loss management. Indeed, semaglutide has long existed in an oral formulation as Rybelsus (an FDA approved medication for Type 2 Diabetes and Cardiovascular Risk Reduction dose in 7mg…
The American Heart Association (AHA) has spent the last eight years revamping the 2017 Hypertension Guidelines, and it shows. There have been a notable number of new recommendations and improvements with an emphasis on prevention and lifestyle modifications. The AHA has also shifted to a more collaborative treatment approach, including nuanced guidance to navigate this…
Sickle cell disease (“SCD”) is an inherited blood cell disorder that causes red blood cells (“RBCs”) to be sickle shaped, which in turn affects how they carry oxygen throughout the body. This can easily block blood flow and cause a variety of complications varying in severity, such as: severe pain crises (e.g., vaso-occlusive crises), infections,…
One of the greatest threats to public health is not another virus—it’s doubt. Vaccine hesitancy is quickly becoming a threat to global health. Pre-pandemic levels, for childhood vaccinations for Measles Mumps Rubella (MMR), Polio, DTaP (diphtheria and whooping cough), were 95% which is high enough to generate Herd Immunity (a.k.a. community immunity). This is when…
A lot of my customers are on Omeprazole (commonly used for heartburn) and Clopidogrel (for stroke and heart attack prevention), this combination gives me heartburn every time I see it (no pun intended). Clopidogrel is often prescribed without respect to Omeprazole because “the patient has been on Omeprazole for ages” and providers often leave staple…
Several significant changes to Medicare have reshaped how millions of Americans access and afford healthcare—especially when it comes to prescription drugs. While many of these changes aimed to improve affordability and access, they’ve, instead, presented a new set of challenges, particularly in rural and underserved communities. Here’s a closer look at key impactful updates we’ve…
